Malak Alharbi: Dual strategy of chemokine modulation followed by checkpoint inhibitors in TNBC

Malak Alharbi, Fellow at Roswell Park Comprehensive Cancer Center, shared on X about a recent paper by Malak Alharbi et al. titled “Targeting the tumor microenvironment to improve clinical outcomes in triple negative breast cancer patients and bridge the current disparity gap” published in PubMed Central.

“Excited to share our new article proposing a dual strategy of chemokine modulation followed by checkpoint inhibitors as an approach to address racial disparity within the TME of TNBC, especially among Black patients.”

Source: Malak Alharbi/X